The Company no longer has the ability to sell its aXOpore® products in Singapore under a special access framework, which is has done for the past nine months. As such, the financial impact of the Singapore regulatory approval is estimated to be around 30-50% of the Company’s revenues from the Singapore region in the past nine months of up to SGD90k. The Company has no past sales history in Vietnam and the financial impact is unknown.
Is this negative or positive?
OSX Price at posting:
30.0¢ Sentiment: Hold Disclosure: Held
